NIH

New player in heart cell growth

Vanderbilt researchers have identified a new protein involved in heart cell growth, which could improve understanding of pathologic cardiac hypertrophy.

VUMC’s Denny named to NIH precision medicine group

Josh Denny, M.D., M.S., associate professor of Biomedical Informatics and Medicine, will help guide planning for the precision medicine initiative announced by President Obama in his January State of the Union Address.

Aging insights from budding yeast

The proteins that control entry and exit from the cell nucleus influence aging, Vanderbilt researchers have discovered.

Grant to boost head and neck lymphedema research

Vanderbilt University School of Nursing (VUSN) has been awarded a four-year, $2.4 million grant from the National Institutes of Health/National Institute of Dental and Craniofacial Research to establish a valid, clinically useful measurement battery for head and neck lymphedema and fibrosis (LEF).

Former postdoc managing NIH career training initiative

Five months ago D’Anne Duncan, Ph.D., was a third-year postdoctoral fellow in ophthalmology and visual neuroscience at Vanderbilt University. Today she’s program manager of a national consortium that is helping scientists-in-training prepare for today’s broad sweep of career options.

Antibiotics with anticancer potential

A series of experimental antibiotics may be a good starting point for developing new anticancer drugs.

1 66 67 68 69 70 104